Japanese Page
sitemap
Home Cpmpany Products Business Report Contact
News
Nikkei Sangyo Shimbun, August 10, 2005
Research and development investment
- Medical research and biotechnology take precedence of business model -
[Brief translation]
The average amount of research and development investment for each company in the previous fiscal year was approximately 82.5 million yen. The top 17 companies out of 30 are in medical and biotechnology fields. Xenesys Inc. (head office in Akashi, Hyogo), a Saga University-launched venture, undertakes the development of an efficient heat exchanger utilized for a power plant through taking advantage of temperature differential in surface and deep seawater. The venture company Xenesys Inc. is in the top 19th position and their research and development investment in fiscal 2005 amounted to 200.69 million yen.